The New Endpoints Reshaping Oncology Trial Design Upcoming Webinar Hosted by Xtalks
Summary
This webinar focuses on how oncology trial design is changing across endpoint selection, eligibility rules, and regulatory expectations. It highlights the growing role of ctDNA, MRD, advanced imaging biomarkers, and patient-reported outcomes in clinical protocols. It also addresses how sponsors can balance innovation with site burden and regulatory risk. The session targets biotech and pharma leaders who write or review oncology protocols.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected